Does Flagyl (metronidazole) treat trichomoniasis, a sexually transmitted infection (STI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Flagyl Treat Trichomoniasis?

Yes, Flagyl (metronidazole) is the primary and FDA-approved treatment for trichomoniasis, achieving cure rates of 90-95% with oral regimens. 1, 2

Recommended Treatment Regimens

The CDC guidelines establish metronidazole as the only oral medication available in the United States for treating trichomoniasis. 1 The FDA has specifically approved metronidazole for both symptomatic and asymptomatic trichomoniasis. 2

First-Line Treatment Options:

  • Preferred regimen: Metronidazole 2 g orally as a single dose 1
  • Alternative regimen: Metronidazole 500 mg orally twice daily for 7 days 1

The 7-day regimen is more effective than single-dose therapy, with treatment failure rates of 11% versus 19% respectively (relative risk 0.55, p<0.0001). 3 This represents the highest quality recent evidence comparing these regimens directly.

Additional FDA-Approved Option:

  • Flagyl 375 mg orally twice daily for 7 days (approved based on pharmacokinetic equivalency, though clinical equivalency data are lacking) 1

Critical Treatment Considerations

Partner Management:

  • Sexual partners must be treated simultaneously to prevent reinfection, regardless of symptoms or culture results 1, 4
  • Patients should abstain from sexual activity until both partners complete treatment and are asymptomatic 1, 4
  • Reinfection from untreated partners is a major cause of apparent treatment failure 1

Why Topical Formulations Don't Work:

  • Metronidazole vaginal gel achieves cure rates below 50% compared to 90-95% with oral therapy 4, 5
  • Topical preparations fail to reach therapeutic levels in the urethra and perivaginal glands where trichomonads reside 1
  • A pilot study confirmed only 44% cure rate with intravaginal metronidazole gel versus 100% with oral therapy 5

Managing Treatment Failures

If initial treatment fails, use this stepwise approach:

  1. First failure: Re-treat with metronidazole 500 mg twice daily for 7 days 1
  2. Repeated failure: Metronidazole 2 g orally once daily for 3-5 days 1
  3. Persistent failure: Consult CDC for expert guidance and susceptibility testing 1

Most metronidazole-resistant strains respond to higher doses, though true resistance does occur. 1, 6 In refractory cases, intravenous metronidazole has shown success when oral regimens fail. 7

Special Populations

Pregnancy:

  • Pregnant women can be treated with the 2 g single-dose regimen 1
  • Treatment is important given associations with preterm delivery, premature rupture of membranes, and low birth weight 1, 6

HIV-Infected Patients:

  • Use the same treatment regimens as HIV-negative patients 1
  • Untreated trichomoniasis increases HIV transmission risk 4, 6

Metronidazole Allergy:

  • Metronidazole desensitization is the recommended approach for documented allergies 4
  • No effective alternative medications exist in the United States 1, 4
  • Desensitization should be performed under medical supervision with appropriate monitoring 4

Common Pitfalls to Avoid

  • Do not use metronidazole vaginal gel as monotherapy for trichomoniasis—it is only effective for bacterial vaginosis 1, 4, 5
  • Do not assume treatment failure without excluding reinfection from untreated partners 1
  • Do not skip partner treatment even if the partner is asymptomatic or has negative cultures, as the organism is difficult to isolate in men 1
  • Follow-up is unnecessary for patients who become asymptomatic after treatment 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.